AIC468
/ AiCuris, Veloxis
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
September 06, 2026
Safety and Pharmacokinetics of AIC468, a Novel Antisense Oligonucleotide Targeting BK-Virus Transcripts, Following Multiple Dosing in Healthy Volunteers
(IDWeek 2026)
- No abstract available
Clinical • PK/PD data • Infectious Disease
September 06, 2026
AIC468, a Novel Antisense Oligonucleotide in Clinical Development for the Treatment of BKV in Kidney Transplant Recipients: Evidence of Broad BKV Strain Coverage and a Low Probability of Pre‑Existing Drug Resistance
(IDWeek 2026)
- No abstract available
Clinical • Infectious Disease
1 to 2
Of
2
Go to page
1